Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for quality of recovery after simple mastectomy
IRCT20141009019470N100Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in breast cancer (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Postoperative pain. Started Aug 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20141009019470N100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N100.